NYSE : AGL
$8.68 (10.0%)
NYSE
Timothy O'Rourke
Medical - Care Facilities
Healthcare
AGL
856
US
USD
0.15
1.08
1.08
0.08
0.00
$5.93B
0.27
7.01
-20.33
-4.69
-$24.5
-$405.35M
-4.24%
-4.23%
-119.35%
-15.78%
-6.21
-1.59
-1.59
$111.00
$141.00
$16.00
1/5
25 Analysts
-13.95%
2.21
3/9
$106.18M
$1.59B
$1.36B
-$262.06M
$1.52B
0.26
-6.49
1.08
-119.35%
-90.22%
-15.74%
-4.92%
48 days
| Name | Title |
|---|---|
| Karthik Rao | Chief Medical Officer |
| Leland Thomas | Senior Manager of Investor Relations |
| Kenny Bellendir | Markets Chief Financial Officer |
| Timothy Gertsch | Chief Accounting Officer |
| Denise Zamore | Chief Legal Officer & Secretary |
| Evan Smith | Senior Vice President of Investor Relations |
| Girish Venkatachaliah | Chief Technology Officer |
| Timothy Patrick O'Rourke | CEO & Director |
| Heidi Hittner | Chief Business Operations Officer |
| Bill Farry | Chief of Technology Innovation |
| Benjamin Shaker | Chief Markets Officer |
| Jeffrey Alan Schwaneke | Executive Vice President & Chief Financial Officer |
No votes yet today — be the first to share your view!
About Agilon Health, Inc. (NYSE:AGL) Stock
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas. ...
agilon health: The Q2 Inflection Is Real
2026-08-07 10:07:53
agilon Health delivered a strong Q2 2026 with revenue of $1.49B, a $250M YoY medical margin swing, and raised FY26 guidance across all key metrics. AGL's operational turnaround is supported by improved cost trends, enhanced data pipelines, and clinical pathway execution, notably reducing inpatient first-diagnosis rates from 25% to under 5%. Balance sheet strength is evident with over $220M net cash, while disciplined membership management supports ongoing profitability.
agilon health, inc. (AGL) Q2 2026 Earnings Call Transcript
2026-08-06 08:14:07
agilon health, inc. (AGL) Q2 2026 Earnings Call Transcript
Agilon Health Q2 Earnings Call Highlights
2026-08-06 04:04:46
Agilon Health NYSE: AGL reported second-quarter results that exceeded its guidance for medical margin and adjusted EBITDA, citing stronger risk-adjustment revenue, favorable medical-cost development and progress in its clinical and quality initiatives. The company also raised its full-year 2026 outlook.
Agilon Health (AGL) Tops Q2 Earnings and Revenue Estimates
2026-08-05 21:36:55
Agilon Health (AGL) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $6.25 per share a year ago.
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
2026-08-05 21:31:06
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
agilon health Reports Second Quarter 2026 Results
2026-08-05 16:05:00
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, the company increased full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA. “Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence i.
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
2026-07-29 09:14:00
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
2026-07-27 10:00:00
Corebridge Financial today announced the addition of Protected Growth Benefit and preset allocation options to select versions of The Power Series of Index Annu
Frequently Asked Questions
What is the current Agilon Health, Inc. (AGL) stock price?
Agilon Health, Inc.(NYSE:AGL) stock price is $95.51 in the last trading session. During the trading session, AGL stock reached the peak price of $133.04 while $7.48 was the lowest point it dropped to. The percentage change in AGL stock occurred in the recent session was 10.0% while the dollar amount for the price change in AGL stock was $8.68.
AGL's industry and sector of operation?
The NYSE listed AGL is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
Who are the executives of AGL?
Karthik Rao
| Chief Medical Officer
Leland Thomas
| Senior Manager of Investor Relations
Kenny Bellendir
| Markets Chief Financial Officer
Timothy Gertsch
| Chief Accounting Officer
Denise Zamore
| Chief Legal Officer & Secretary
How many employees does AGL have?
Number of AGL employees currently stands at 856. AGL operates from 440 Polaris Parkway, Westerville, OH 43082, US.
Link for AGL official website?
Official Website of AGL is: https://agilonhealth.com
How do I contact AGL?
AGL could be contacted at phone #562 256 3800 and can also be accessed through its website. AGL operates from 440 Polaris Parkway, Westerville, OH 43082, US.
How many shares of AGL are traded daily?
The average number of AGL shares traded daily for last 3 months was 403.28K.
What is the market cap of AGL currently?
The market value of AGL currently stands at $1.59B with its latest stock price at $95.51